ClinicalTrials.gg
CompletedNCT03337230Updated Mar 16, 2021

Feasibility of a Social Media-based Weight Loss Program for Low Socioeconomic Status Individuals

An interventional study of Physical Activity and Diet in Obesity, sponsored by Case Comprehensive Cancer Center. Completed at 1 site in United States. Open to participants aged 35 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-16.

Sponsored by Case Comprehensive Cancer Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Not applicable
Ages
35 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to see if it is practical to use social media-based and traditional online weight loss intervention components among low socioeconomic status participants using the Facebook social media (SM) and Fitbit self-monitoring platforms. Also, the study will test the effectiveness of recruiting participants via social media and at community events and locations. The results of this study will be used to inform future research studies.

Read the detailed description

The primary objectives of the proposed research are to:

  1. assess the feasibility of social media-based (social support, social competition, and social rewards) and traditional online weight loss (education and goal setting) intervention components delivered to low-Socioeconomic Status (SES) participants using the Facebook SM and Fitbit self-monitoring platforms and
  2. develop and assess methods for recruiting and retaining adequate numbers of low-SES participants for a future randomized controlled trial to assess the efficacy of an SM-based weight loss intervention. The study team will assess feasibility by conducting a 12-week pilot test of traditional and social media-based weight loss intervention components followed by qualitative and quantitative assessment with pilot participants.

The specific aims are:

Aim 1- Assess trial feasibility: The study team will assess intervention processes critical to the success of a larger efficacy trial during the 12-week pilot including: (1) participant recruitment and retention, (2) participant use of intervention components, (3) use of data collection strategies and instruments.

Aim 2 - Assess intervention acceptability: The study team will conduct structured interviews and surveys among participants to assess participants' experience during the intervention. This study focuses on: (1) intervention design and content, (2) participant use of intervention technologies (Facebook and Fitbit), (3) participant concerns about privacy, and (4) barriers and facilitators to recruitment, retention, and participation. Findings will be used to improve the design of a larger efficacy trial.

Study Design: This study will employ a one group pre-post design.

02

Conditions studied

  • Obesity

Keywords

  • Cancer
  • Weight-Loss
  • Social Media
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's enrollment of 55 is below the median of 67 across 9,006 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Case Comprehensive Cancer Center is the lead sponsor of 494 studies on the registry; 61 are open to participants now.

Of its 75 completed or terminated interventional studies of FDA-regulated products, 46 (61%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • able to speak English
  • regular access to an internet-enabled device that can be synched with the Fitbit wristband
  • (BMI) 25-40 kg/m\^2
  • \< 30 minutes per day of self-reported moderate or vigorous physical activity
  • Considered eligible for Ohio Expanded Food and Nutrition Education Program (EFNEP) income guidelines
  • located in the greater Cleveland metropolitan area
  • not pregnant or planning on becoming pregnant
  • answers 'no' to all questions on the PA Readiness Questionnaire (PAR-Q) or is cleared in writing by a physician
  • does not have a recent history of alcohol or drug abuse or is in treatment
  • does not have schizophrenia

Exclusion criteria

Exclusion Criteria:

  • Does not meet all inclusion criteria
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
55 participants (actual)

Study arms

  • Experimental
    Physical Activity + Diet + Social media

    Educational materials for the proposed study will be delivered via a secret social media Facebook group. These materials will promote simple, attainable forms of Physical Activity and lasting diet changes. A study moderator will deliver weekly communications to the Facebook group providing intervention content including social support, social competition and comparison, and social rewards

    Behavioral: Physical Activity · Behavioral: Diet · Behavioral: Social Support

Interventions

  • BehavioralPhysical Activity

    Fitbit Activity Monitor and IPAQ to give level of physical activity. Participants will be provided with education about physical activity recommendations and will be encouraged to set goals for improvement.

  • BehavioralDiet

    National Cancer Institute's ASA24 web-based dietary assessment tool to determine intake. Participants will be provided with education about healthy diets and will be encouraged to set goals for making enduring changes to dietary intake.

  • BehavioralSocial Support

    Social support will be determined via self report scale measure and objective collection of social media communications. Each participant will be contacted through social media regularly with dietary and physical activity information and asked to support other participants via encouragement and sharing of information.

06

What researchers measure

Primary outcomes

  1. Ratio or participants screened to patients completing 12-week measures

    This is a measure of feasibility

    Time frame: Up to 12 weeks

  2. Average score of adapted INSHAPE computer-based questionnaire

    Computer-based questionnaires will be self-administered via the Qualtrics Survey platform. INSHAPE questionnaire is a 14 question survey gauging acceptability of the program

    Time frame: Up to 12 weeks

Secondary outcomes

  1. Number of eligible participants

    This is a measure of feasibility

    Time frame: Up to 12 weeks

  2. Number of consented participants

    This is a measure of feasibility

    Time frame: Up to 12 weeks

  3. Average change in Fitbit activity

    This is a measure of physical activity

    Time frame: From baseline to 12 weeks

  4. Average change in International physical activity questionnaire (IPAQ) score

    This is a measure of physical activity

    Time frame: From baseline to 12 weeks

  5. Average change in score of the National Cancer Institute's Automated Self-Administered 24-Hour (ASA24) dietary assessment web-based assessment tool

    This is a measure of dietary intake

    Time frame: From baseline to 12 weeks

  6. Change in weight

    Trained study staff will determine weight at baseline and 12 weeks of the study

    Time frame: From baseline to 12 weeks

  7. Change in waist circumference

    Trained study staff will determine waist circumference at baseline and 12 weeks of the study

    Time frame: From baseline to 12 weeks

  8. Average change in social support score

    This is a 31 question, multiple choice survey adapted from Gruber and Sallis

    Time frame: From baseline to 12 weeks

  9. Average change in weight loss self-efficacy score

    Multiple choice questions and short answer survey which can be scored to gauge weight-loss self-efficacy. Adapted from Wilson

    Time frame: From baseline to 12 weeks

  10. Average change in dietary knowledge

    Multiple choice questions and short answer survey which can be scored to gauge dietary knowledge. Adapted from Jones

    Time frame: From baseline to 12 weeks

07

Study locations

1 site
  • Case Western Reserve Univeristy
    Cleveland, Ohio 44106, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2017 to primary completion in Jun 2018, 7 months.

Of 3,680 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 7 months is below that.

Counting every sponsor, half of 3,843 studies reached it within 22 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2017
First posted
Nov 8, 2017
StartActual
Oct 31, 2017
Primary completionActual
Jun 1, 2018
CompletionActual
Jun 1, 2018
Last update
Mar 16, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03337230
Responsible party
Sponsor
First posted
Nov 8, 2017
Start date
Oct 31, 2017
Primary completion
Jun 1, 2018
Completion
Jun 1, 2018
Last update
Mar 16, 2021

Study contacts

David N. Cavallo, PhD MPH RDN
principal investigator · Case Comprehensive Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion